Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.140
0.00 (0.00%)
Apr 29, 2026, 3:57 PM HKT
-2.56%
Market Cap 1.71B
Revenue (ttm) 1.37B
Net Income (ttm) 238.11M
Shares Out 1.50B
EPS (ttm) 0.16
PE Ratio 7.32
Forward PE n/a
Dividend 0.06 (5.53%)
Ex-Dividend Date May 27, 2026
Volume 48,000
Average Volume 180,800
Open 1.150
Previous Close 1.140
Day's Range 1.140 - 1.150
52-Week Range 1.060 - 1.470
Beta 0.26
RSI 52.24
Earnings Date Mar 27, 2026

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-all... [Read more]

Sector Healthcare
Founded 1995
Employees 1,116
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2348
Full Company Profile

Financial Performance

In 2025, HKG:2348's revenue was 1.23 billion, an increase of 16.09% compared to the previous year's 1.06 billion. Earnings were 213.97 million, a decrease of -62.13%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.